Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Scleroderma can impair vitamin D3 absorption because the disease damages smooth muscle in the small intestine, slowing motility and allowing bacteria to multiply where they normally should not thrive. This small intestinal bacterial overgrowth (SIBO) deconjugates bile salts, and without functioning bile salts, fat-soluble vitamins like D3 cannot form the micelles required for uptake across the intestinal wall. Fibrosis of the gut lining further reduces the absorptive surface area, meaning even high oral doses may produce little rise in blood levels. Correcting the deficiency often requires treating the overgrowth first, then using higher doses, liquid or sublingual forms, or injections while monitoring levels. There are several important factors that influence which approach works best, including calcium, bile acid status, and interactions with other medications, so review the details below before changing your regimen.
Last reviewed for medical accuracy: 08/18/2026
Patients with systemic sclerosis (scleroderma) often face digestive challenges that go beyond heartburn or mild discomfort. One major issue is malabsorption, where the body can’t take up vital nutrients. Among these, vitamin D3 is crucial for bone health. When vitamin D3 absorption falters, patients risk developing osteomalacia—a softening of the bones. In systemic sclerosis, small intestinal bacterial overgrowth (SIBO) is a key culprit.
Systemic sclerosis causes fibrosis (scarring) of tissues, including the muscles in your digestive tract. This leads to:
Over time, these changes set the stage for SIBO and nutrient malabsorption.
SIBO occurs when bacteria from the colon migrate and overpopulate the small intestine. Normally, the small bowel has relatively few bacteria compared to the colon. When too many bacteria live in the small intestine, they:
This creates a vicious cycle: poor motility leads to SIBO, and SIBO further damages motility.
Vitamin D3 (cholecalciferol) is a fat-soluble vitamin absorbed in the upper small intestine. SIBO interferes with this process in several ways:
Competition for Nutrients
Bacteria use up bile salts and fatty acids needed to form micelles, the vehicles that carry fat-soluble vitamins across the intestinal wall.
Deconjugation of Bile Salts
Overgrown bacteria produce enzymes that break down bile salts, reducing fat digestion and disrupting vitamin D3 uptake.
Mucosal Damage
Bacterial toxins injure the intestinal lining, decreasing its ability to absorb nutrients.
Inflammation
Chronic low-grade inflammation alters gut permeability and enzyme activity, further impairing absorption.
When vitamin D3 levels stay low, calcium absorption in the gut drops. The body responds by pulling calcium from bones, leading to:
This bone-softening condition is known as osteomalacia. In systemic sclerosis, connective tissue changes in blood vessels and skin often gloss over these symptoms, delaying diagnosis.
Because scleroderma itself can cause fatigue, joint pain and skin tightness, it’s easy to dismiss early signs of osteomalacia. Watch for:
If you or your doctor suspect malabsorption or osteomalacia, key tests include:
Treating SIBO is the first step toward improving vitamin D3 absorption. Approaches include:
• Antibiotic Therapy
– Rifaximin is commonly used due to minimal systemic absorption.
– Rotating antibiotics (e.g., metronidazole, ciprofloxacin) may be needed for recurrent cases.
• Prokinetic Agents
– Medications like prucalopride or low-dose erythromycin help normalize small bowel motility.
– Improved transit reduces bacterial overgrowth.
• Dietary Adjustments
– A low-FODMAP diet limits fermentable carbs that feed bacteria.
– Elemental or semi-elemental formulas may be used short-term to rest the gut.
• Probiotics and Prebiotics
– Certain probiotic strains can compete with pathogenic bacteria.
– Prebiotics selectively nourish beneficial microbes.
Even with SIBO controlled, damaged gut lining may still absorb fat poorly. Strategies include:
Ongoing care is crucial. Steps to stay ahead of SIBO and osteomalacia:
Quality of life improves when nutrient deficiencies are caught early. If you’re concerned about symptoms or suspect malabsorption, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Osteomalacia and severe SIBO can lead to complications. Contact a healthcare provider right away if you experience:
Always speak to a doctor about anything that could be life-threatening or serious. Only a qualified medical professional can provide personalized diagnosis and treatment.
Osteomalacia in patients with systemic sclerosis isn’t inevitable. With vigilance and coordinated care, you can protect your bones and improve overall well-being. If you have new or worsening symptoms, please speak to a doctor as soon as possible.
(References)
* Tamborrini G, Distler M, Distler O. [Systemic sclerosis]. Med Monatsschr Pharm. 2008 May;31(5):162-70; quiz 171-2. PMID: 18552072.
* Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28;16(24):2978-90. doi: 10.3748/wjg.v16.i24.2978. PMID: 20572300; PMCID: PMC2890937.
* Sharma N, Cooney R, Cooper SC. Venting issues. Frontline Gastroenterol. 2021;12(3):259-260. doi: 10.1136/flgastro-2019-101273. Epub 2019 Oct 14. PMID: 33907622; PMCID: PMC8040504.
* Nassar M, Ghernautan V, Nso N, Nyabera A, Castillo FC, Tu W, Medina L, Ciobanu C, Alfishawy M, Rizzo V, Eskaros S, Mahdi M, Khalifa M, El-Kassas M. Gastrointestinal involvement in systemic sclerosis: An updated review. Medicine (Baltimore). 2022 Nov 11;101(45):e31780. doi: 10.1097/MD.0000000000031780. PMID: 36397401; PMCID: PMC9666124.
* McMahan ZH, Kulkarni S, Chen J, Chen JZ, Xavier RJ, Pasricha PJ, Khanna D. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management. Nat Rev Rheumatol. 2023 Mar;19(3):166-181. doi: 10.1038/s41584-022-00900-6. Epub 2023 Feb 6. PMID: 36747090.
* Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023 Jun 3;401(10391):1878-1890. doi: 10.1016/S0140-6736(23)00457-9. Epub 2023 May 5. PMID: 37156255.
* Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, Letyagina Y, Kozlov E, Levshina A, Ivashkin V. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023 Jun 14;29(22):3400-3421. doi: 10.3748/wjg.v29.i22.3400. PMID: 37389240; PMCID: PMC10303511.
* Singh M, Wambua S, Lee SI, Okoth K, Wang Z, Fazla F, Fayaz A, Eastwood KA, Nelson-Piercy C, Nirantharakumar K, Crowe F, MuM-PreDiCT. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. Lancet. 2023 Nov;402 Suppl 1:S84. doi: 10.1016/S0140-6736(23)02128-1. PMID: 37997130.
* Singh M, Wambua S, Lee SI, Okoth K, Wang Z, Fayaz FFA, Eastwood KA, Nelson-Piercy C, Reynolds JA, Nirantharakumar K, Crowe F, MuM-PreDiCT. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Med. 2024 Mar 5;22(1):94. doi: 10.1186/s12916-024-03309-y. Epub 2024 Mar 5. PMID: 38438886; PMCID: PMC10913233.
* Kashyap P, Moayyedi P, Quigley EMM, Simren M, Vanner S. Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterol Motil. 2024 Jun;36(6):e14817. doi: 10.1111/nmo.14817. Epub 2024 May 26. PMID: 38798120; PMCID: PMC11268457.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.